ORLAM, a group of oncologists working in 3 radiotherapy centers in Lyon and 1 in Mâcon in France and United Imaging Healthcare announced during ESTRO 2026 a strategic partnership to bring the CE-Marked uRT-linac 506c to France, marking the first installation of its kind in France and bringing next generation personalized radiotherapy to patients in France. United Imaging's longstanding partner Qualimedis, a leading French provider of innovative products and quality assurance solutions in the fields of imaging and radiotherapy, has been instrumental in making this collaboration a success.
"At ORLAM, we believe every patient should have access to the most advanced and effective cancer treatments available. By partnering with United Imaging Healthcare Europe and introducing the CE-marked uRT-linac 506c in France, we are taking an important step toward expanding access to next-generation precision therapy, notably routine online CT-guided adaptive radiotherapy. This collaboration reflects our ongoing commitment to innovation, clinical excellence, and delivering high-quality care close to where our patients live." – Dr Séna Yossi, Managing Partner & Co-Medical Director, ORLAM.
"We are proud to partner with ORLAM in a collaboration built on shared commitment to innovation, clinical excellence, and improving access to advanced cancer care. Together, we are introducing the uRT-linac 506c to France, expanding access to next- generation precision radiotherapy and helping ensure that more patients can benefit from high-quality, cutting-edge treatment close to home." - Prof. Chen, CEO, United Imaging Healthcare Europe.
Taking the next step in personalized radiotherapy
The CE-Marked uRT-linac 506c system from United Imaging features a diagnostic-quality CT scanner integrated with the linear accelerator on a single platform, enabling a streamlined workflow from CT image guidance to treatment delivery. A key feature of the uRT-linac 506c is the acquisition of high-definition diagnostic CT images immediately prior to each treatment fraction, allowing clinicians to visualize anatomical and tumor changes and perform online adaptive treatment planning to support personalized radiotherapy.
In addition, the system's capabilities, enabled by native AI, support the entire workflow, including automated contouring of organs-at-risk and target volumes, automated treatment planning, EPID-based quality assurance, and trajectory planning.
Partnership
The partnership underscores United Imaging's growing presence in Europe and reinforces its mission to make advanced diagnostic and treatment technologies more accessible to healthcare providers and patients around the globe.